|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 2.090 USD | +1.95% |
|
+5.03% | +16.11% |
| 13.05. | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13.05. | Protalix BioTherapeutics, Inc. veröffentlicht Ergebniszahlen für das erste Quartal zum 31. März 2026 | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.95% | +5.03% | +9.42% | -25.09% | +16.11% | +35.71% | -7.52% | -3.69% | -72.82% | 168 Mio. | |
| -2.41% | +0.14% | +14.46% | +15.94% | +5.43% | +39.53% | +154.43% | +405.60% | +1’432.12% | 1’010 Mrd. | |
| +1.07% | +3.48% | +7.41% | -0.48% | +16.39% | +53.75% | +50.64% | +46.02% | +105.85% | 580 Mrd. | |
| +1.32% | +0.22% | +9.56% | +1.05% | -0.33% | +18.35% | +65.35% | +97.31% | +273.33% | 402 Mrd. | |
| +0.77% | 0.00% | +1.74% | +2.80% | -0.34% | +19.99% | +16.80% | -4.36% | +30.42% | 330 Mrd. | |
| -1.42% | -1.44% | +5.94% | +2.71% | +13.10% | +45.50% | +8.37% | +56.09% | +109.56% | 294 Mrd. | |
| -0.85% | -2.86% | -2.08% | -6.28% | -2.38% | +22.05% | +13.80% | +61.41% | +249.48% | 280 Mrd. | |
| +0.44% | +3.48% | +5.33% | +1.03% | +11.39% | +24.48% | +34.39% | +46.52% | +60.10% | 281 Mrd. | |
| +1.66% | +1.20% | -3.12% | +16.30% | -11.68% | -44.67% | -47.49% | +11.16% | +57.61% | 197 Mrd. | |
| +0.32% | +1.61% | +5.62% | -3.42% | +8.52% | +19.48% | +63.42% | +46.31% | +129.49% | 192 Mrd. | |
| -0.22% | -2.76% | -6.93% | -13.51% | +2.32% | +12.08% | +61.30% | +82.62% | +48.72% | 156 Mrd. | |
| +0.15% | +0.65% | +1.31% | -2.42% | +5.26% | +5.52% | -34.31% | -34.72% | -25.73% | 149 Mrd. | |
| +0.40% | -0.24% | +1.20% | -3.09% | +5.91% | +12.70% | -11.78% | -15.16% | -21.36% | 117 Mrd. | |
| -0.03% | -0.43% | -0.75% | -6.94% | -1.86% | -3.29% | +30.63% | +130.51% | +386.31% | 113 Mrd. | |
| +0.38% | -1.74% | +4.40% | +0.09% | -7.41% | -12.65% | -19.40% | -13.85% | +8.73% | 106 Mrd. | |
| +1.10% | +2.37% | +4.89% | -2.31% | +8.74% | +28.04% | +44.42% | +13.10% | +12.29% | 106 Mrd. | |
| +0.30% | -1.38% | -4.41% | -20.99% | -9.62% | -1.31% | +84.00% | +70.17% | +485.85% | 76.54 Mrd. | |
| +0.97% | +3.17% | -1.66% | -10.29% | +5.11% | +16.16% | +12.83% | +34.48% | +11.62% | 50.12 Mrd. | |
| +3.21% | +2.99% | -13.58% | -12.31% | -18.60% | -13.13% | +8.48% | -33.54% | +235.95% | 47.41 Mrd. | |
| +1.12% | +0.08% | -5.85% | -7.51% | -2.22% | +30.09% | -29.19% | -32.32% | -58.88% | 41.16 Mrd. | |
| Durchschnitt | +0.27% | +0.81% | +1.65% | -3.74% | +2.19% | +15.42% | +24.96% | +48.18% | +172.93% | 226.5 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.57% | +0.78% | +5.59% | +2.69% | +4.59% | +25.00% | +55.51% | +122.91% | +414.38% |
- Börse
- Aktien
- A2PWSL Aktie
- Sektor Protalix BioTherapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
